Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125376621 | 12537662 | 1 | I | 20160623 | 20160707 | 20160707 | EXP | KP-SHENZHEN TECHDOW PHARMACEUTICAL CO. LTD-KR-2016TEC0000022 | SHENZHEN TECHDOW PHARMACEUTICAL | LEE S-E, JO H-B, MOON H-H, OH D-J, KWON K-H, KWON J-H, ET AL.. SPONTANEOUS BLEEDING FROM INTERNAL PUDENDAL ARTERY ASSOCIATED WITH ABCIXIMAB AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION: SUCCESSFUL TREATMENT WITH PERCUTANEOUS GEL-FOAM EMBOLIZATION.. KOREAN CIRC J.. 2016;46(2):256-259 | 53.00 | YR | M | Y | 0.00000 | 20160707 | MD | KP | KP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125376621 | 12537662 | 1 | PS | Heparin Sodium Injection USP, Preservative Free | HEPARIN SODIUM | 1 | 6 U/KG/HR | Y | 202732 | INJECTION | |||||||||
| 125376621 | 12537662 | 2 | SS | Heparin Sodium Injection USP, Preservative Free | HEPARIN SODIUM | 1 | 860 U/H INFUSION | Y | 202732 | INJECTION | |||||||||
| 125376621 | 12537662 | 3 | SS | Heparin Sodium Injection USP, Preservative Free | HEPARIN SODIUM | 1 | 4000 U BOLUS | Y | 202732 | INJECTION | |||||||||
| 125376621 | 12537662 | 4 | SS | ABCIXIMAB | ABCIXIMAB | 1 | Intravenous (not otherwise specified) | 0.125 ?G/KG/MIN, CONTINUOUS INFUSION | Y | 0 | .125 | UG/KG | INFUSION | ||||||
| 125376621 | 12537662 | 5 | SS | ABCIXIMAB | ABCIXIMAB | 1 | Intravenous (not otherwise specified) | 0.25 MG/KG, BOLUS | Y | 0 | .25 | MG/KG | INFUSION | ||||||
| 125376621 | 12537662 | 6 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | 300 MG, UNK | U | 0 | 300 | MG | ||||||||
| 125376621 | 12537662 | 7 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 300 MG, UNK | U | 0 | 300 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125376621 | 12537662 | 1 | Acute myocardial infarction |
| 125376621 | 12537662 | 4 | Vascular stent thrombosis |
| 125376621 | 12537662 | 6 | Acute myocardial infarction |
| 125376621 | 12537662 | 7 | Acute myocardial infarction |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125376621 | 12537662 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125376621 | 12537662 | Blood pressure decreased | |
| 125376621 | 12537662 | Heart rate increased | |
| 125376621 | 12537662 | Hypovolaemic shock | |
| 125376621 | 12537662 | Puncture site haemorrhage | |
| 125376621 | 12537662 | Scrotal swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |